CVS Health Reports Third Quarter Results With Diversified Assets Delivering Strong Enterprise Performance

Go back to CVS Health Reports Third Quarter Results With Diversified Assets Delivering Strong Enterprise Performance

CVS Health (CVS) Tops Q3 EPS by 33c, Raises FY EPS Guidance

November 6, 2020 6:32 AM EST

CVS Health (NYSE: CVS) reported Q3 EPS of $1.66, $0.33 better than the analyst estimate of $1.33. Revenue for the quarter came in at $67.1 billion versus the consensus estimate of $66.58 billion.

GUIDANCE:

CVS Health sees FY2020 EPS of $7.35-$7.45, versus the consensus... More